Trademark Filing
Telix Pharmaceuticals Limited
| Serial Number | 79360061 |
| Mark Drawing Code | 2000: Illustration: Drawing or design without any word(s)/letter(s)/ number(s) |
Timeline
| 2022-08-29 | Application Filed |
| 2023-01-12 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2023-01-12 | Status: Live/Pending |
| 2023-01-13 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Telix Pharmaceuticals Limited |
| Entity Statement | Limited company |
| Address | Suite 401, 55 Flemington Road North Melbourne VIC 3051 AU |
| Legal Entity Type | |
| Legal Entity State | AU |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260104 | Circles with two breaks or divided in the middle |
| 260121 | Circles that are totally or partially shaded. |
| 260131 | Circles |
| 261702 | Bands, wavy; Bars, wavy; Lines, wavy; Wavy line(s), band(s) or bar(s) |
| 261706 | Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Chemicals for pharmaceutical use; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; none of the aforementioned for use in the treatment, prevention or diagnosis of central nervous system diseases and disorders |
| DM0000 | The mark consists of an incomplete circle with two curved lines and nine shaded circles separating the two sides of the incomplete circle. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2023-01-12 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2023-01-13 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2023-01-17 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-04-06 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-04-11 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-04-12 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-06-06 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-06-06 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-06-26 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-11-29 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-11-29 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-11-29 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-01-02 | 13 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-01-17 | 14 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2024-01-17 | 15 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-01-17 | 16 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2024-02-06 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-02-06 | 18 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2024-02-06 | 19 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2024-04-23 | 20 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-04-23 | 21 NRCC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 